ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,088 filers reported holding ASTRAZENECA PLC in Q2 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $496,172 | +7.4% | 6,362 | -6.7% | 0.12% | +10.4% |
Q1 2024 | $462,191 | -2.3% | 6,822 | -2.8% | 0.11% | -9.4% |
Q4 2023 | $472,932 | -9.1% | 7,022 | -8.6% | 0.12% | -17.0% |
Q3 2023 | $520,225 | -12.3% | 7,682 | -7.4% | 0.14% | -10.2% |
Q2 2023 | $593,458 | +1.8% | 8,292 | -1.3% | 0.16% | -7.1% |
Q1 2023 | $582,905 | +3.2% | 8,398 | +0.8% | 0.17% | -2.9% |
Q4 2022 | $564,842 | +23.3% | 8,331 | -0.3% | 0.17% | +10.8% |
Q3 2022 | $458,000 | -15.8% | 8,353 | +1.3% | 0.16% | -13.3% |
Q2 2022 | $544,000 | +29.2% | 8,243 | +29.6% | 0.18% | +54.7% |
Q1 2022 | $421,000 | +35.8% | 6,360 | +19.4% | 0.12% | +46.2% |
Q4 2021 | $310,000 | +6.9% | 5,325 | +10.0% | 0.08% | +1.3% |
Q3 2021 | $290,000 | +2.5% | 4,840 | +2.3% | 0.08% | -1.2% |
Q2 2021 | $283,000 | +28.1% | 4,733 | +6.4% | 0.08% | +17.6% |
Q1 2021 | $221,000 | +4.2% | 4,450 | +4.7% | 0.07% | 0.0% |
Q4 2020 | $212,000 | -32.9% | 4,250 | -26.5% | 0.07% | -41.4% |
Q3 2020 | $316,000 | -2.5% | 5,783 | -5.7% | 0.12% | -13.4% |
Q2 2020 | $324,000 | +15.7% | 6,135 | -2.4% | 0.13% | -6.9% |
Q1 2020 | $280,000 | +133.3% | 6,289 | +160.7% | 0.14% | +213.0% |
Q4 2019 | $120,000 | – | 2,412 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |